R
Rafael Golpe
Researcher at University of Cantabria
Publications - 133
Citations - 2520
Rafael Golpe is an academic researcher from University of Cantabria. The author has contributed to research in topics: Medicine & COPD. The author has an hindex of 21, co-authored 107 publications receiving 1990 citations.
Papers
More filters
Journal ArticleDOI
Short-term and long-term effects of nasal intermittent positive pressure ventilation in patients with obesity-hypoventilation syndrome.
Luis Pérez de Llano,Rafael Golpe,Montserrat Ortiz Piquer,Alejandro Veres Racamonde,Manuel Vázquez Caruncho,Olga Caballero Muinelos,Cristina Alvarez Carro +6 more
TL;DR: NIPPV therapy is effective in the treatment of patients with OHS, providing a significant improvement in clinical status and gas exchange, and dyspnea decreased in all but four patients.
Journal ArticleDOI
Lemierre's syndrome (necrobacillosis).
TL;DR: Lemierre's syndrome or postanginal septicaemia (necrobacillosis) is caused by an acute oropharyngeal infection with secondary septic thrombophlebitis of the internal jugular vein and frequent metastatic infections.
Journal ArticleDOI
Obesity-hypoventilation syndrome: increased risk of death over sleep apnea syndrome.
Olalla Castro-Añón,Luis Pérez de Llano,Sandra de la Fuente Sánchez,Rafael Golpe,Lidia Méndez Marote,Julián Castro-Castro,Arturo González Quintela +6 more
TL;DR: Mortality of severe OHS is high and substantially worse than that of OSAS, and should be considered a systemic disease that encompasses respiratory, metabolic and cardiovascular components that require a multimodal therapeutic approach.
Journal ArticleDOI
Utility of home oximetry as a screening test for patients with moderate to severe symptoms of obstructive sleep apnea.
TL;DR: The greatest value of oximetry in this setting seems to be as a tool to rapidly recognize and treat more severe OSA patients in waiting list for PSG.
Journal ArticleDOI
Long-term clinical effectiveness of continuous positive airway pressure therapy versus non-invasive ventilation therapy in patients with obesity hypoventilation syndrome: a multicentre, open-label, randomised controlled trial
Juan F. Masa,Babak Mokhlesi,Iván Benítez,Francisco Javier Gómez De Terreros,Maria A. Sanchez-Quiroga,Auxiliadora Romero,Candela Caballero-Eraso,Joaquín Terán-Santos,María Luz Alonso-Álvarez,Maria F. Troncoso,Mónica González,Soledad López-Martín,Jose M. Marin,Sergi Marti,Trinidad Díaz-Cambriles,Eusebi Chiner,Carlos Egea,Javier Barca,Francisco-José Vázquez-Polo,Miguel Ángel Negrín,María Martel-Escobar,Ferran Barbé,Jaime Corral,Galo Fernández,Estrella Ordax-Carbajo,Nicolás González-Mangado,Teresa Gomez-Garcia,Maria-Ángeles Martinez-Martinez,Elena Ojeda-Castillejo,Daniel López Padilla,Santiago J. Carrizo,Begoña Gallego,Mercedes Pallero,Odile Romero,Maria Antonia Ramon,Eva Arias,Jesús Muñoz-Méndez,Cristina Senent,José N. Sancho-Chust,Nieves Belén Navarro Soriano,Emilia Barrot,José M. Benítez,Jesús Sanchez-Gómez,Rafael Golpe,Ana Santiago-Recuerda,Silvia Gómez,Mónica Bengoa +46 more
TL;DR: In stable patients with obesity hypoventilation syndrome and severe obstructive sleep apnoea, non-invasive ventilation and continuous positive airway pressure have similar long-term effectiveness.